drugset / Trial / NCT00130026
Caffeine in the Prevention of Post-operative Nausea and Vomiting
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of this study is to determine if caffeine 500 mg intravenously is efficacious when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and vomiting (PONV) in patients undergoing ambulatory surgery under general anesthesia.
Timeline
- Start
- 2005-03
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Caffeine | Small molecule | 500 mg | Intravenous |
Indications
No indication recorded.